Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 743.35
-11.70 (-1.55%)
At close: Mar 6, 2026
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 15.58 billion as of March 6, 2026. Its market cap has decreased by -10.74% in one year.
Market Cap
15.58B
Enterprise Value
13.29B
Revenue
8.68B
Ranking
n/a
PE Ratio
23.65
Stock Price
743.35
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 15.58B, an increase of 75.58%. That is a compound annual growth rate of 13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 15.58B | -6.50% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indoco Remedies | 18.31B |
| Ind-Swift Laboratories | 11.87B |
| Sakar Healthcare | 11.75B |
| Jagsonpal Pharmaceuticals | 11.59B |
| Beta Drugs | 11.08B |
| Solara Active Pharma Sciences | 22.11B |
| Orchid Pharma | 27.32B |
| RPG Life Sciences | 30.97B |